Medpace Holdings Inc
NASDAQ:MEDP
Medpace Holdings Inc
Revenue
Medpace Holdings Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Medpace Holdings Inc
NASDAQ:MEDP
|
Revenue
$2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Revenue
$42.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
Danaher Corp
NYSE:DHR
|
Revenue
$43.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
21%
|
CAGR 10-Years
9%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Revenue
$3.8B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Agilent Technologies Inc
NYSE:A
|
Revenue
$6.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Revenue
$15.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
11%
|
Medpace Holdings Inc
Revenue Breakdown
Breakdown by Geography
Medpace Holdings Inc
Breakdown by Segments
Medpace Holdings Inc
Total Revenue:
1.9B
USD
|
Revenue Net:
1.9B
USD
|
Oncology:
587.1m
USD
|
Other:
404.8m
USD
|
Metabolic:
376.8m
USD
|
Cardiology:
193.7m
USD
|
Avai:
163.3m
USD
|
Central Nervous System:
160.1m
USD
|
See Also
What is Medpace Holdings Inc's Revenue?
Revenue
2B
USD
Based on the financial report for Mar 31, 2024, Medpace Holdings Inc's Revenue amounts to 2B USD.
What is Medpace Holdings Inc's Revenue growth rate?
Revenue CAGR 5Y
21%
Over the last year, the Revenue growth was 26%. The average annual Revenue growth rates for Medpace Holdings Inc have been 27% over the past three years , 21% over the past five years .